An open study of methylphenidate in bipolar depression

Bipolar Disorders

Volumn 2, Issue 1, 2000, Pages 56-59

  El Mallakh, Rif S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Bipolar depression; Methylphenidate; Treatment

Indexed keywords

AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; METHYLPHENIDATE;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL TRIAL; DRUG COMBINATION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MALE; PSYCHOLOGICAL RATING SCALE;

ADULT; AMPHETAMINES; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHYLPHENIDATE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 0034157871     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2000.020108.x     Document Type: Article

References (30)

1. El-Mallakh RS. Lithium: Actions and Mechanisms. Washington, DC: American Psychiatric Press, 1994.
2. Müller-Oerlinghausen B, Müser-Causenmann B, Volk J. Suicides and parasuicides in a high risk patent group on and off lithium lone-term medication. J Affect Disord 1992; 25: 261-269.
3. Nilsson A. Mortality in recurrent mood disorders during periods on and off lithium: a complete population study in 362 patients. Pharmacopsychiatry 1995; 28: 8-13.
4. Ahrens B, Müller-Oerlinghausen B, Schou M, Wolf T, Aida M, Grof E, Grof P, Lenz G, Simhardl C, Thau K, Vestergaard P, Wolf R, Möller HJ. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord 1995; 33: 67-75.
5. McElroy SL, Keck PE, Pope HG Jr, Hudson JI. Valproate in bipolar disorder: literature review and treatment guidelines. J Clin Psychopharmcol 1992; 12: 42S-52S.
6. Greil W, Ludwig-Mayerhofer W, Erazo N, Schöchlin C, Schmidt S, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterung T. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - a randomized study. J Affect Disord 1997; 43: 151-161.
7. Himmelhoch JM, Thase ME, Mallinger AG, Houck P. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991; 148: 910-916.
8. Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993; 13: 397-408.
9. Sachs GS, Lafer B, Stoll AL. A double-blind trial of bupopion versus desipramine for bipolar disorder. J Clin Psychiatry 1994; 55: 391-393.
10. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36: 555-559.
11. Fogleson DL, Bystritsky A, Pasnau R. Bupopion in the treatment of bipolar disorders: the same old story? J Clin Psychiatry 1992; 53: 443-446.
12. Stoll AL, Mayer PB, Kolbrener M, Goldstein E, Suplit B, Lucier J, Cohen BM, Tohen M. Antidepressant associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry 1994; 151: 1642-1645.
13. Post RM. Prophylaxis of bipolar disorders. Int Rev Psychiatry 1990; 2: 277-320.
14. Angst J. Switch from depression to mania: a record study over decades between 1920 and 1982. Psychopathology 1985; 18: 140-154.
15. Rouillon F, Lejoyeux M, Filteau MJ. Unwanted effects of long term treatment. In: Mongomery SA, Rouillan FA, eds. Long Term Treatment of Depression. London: Wiley and Sons, 1992; 81-111.
16. El-Mallakh RS. New insights into the course and prognosis of bipolar illness. Psychiatric Annals 1997; 27: 478-481.
17. Katon W, Raskind M. Treatment of depression in the medically ill elderly with methylphenidate. Am J Psychiatry 1980; 137: 963-965.
18. Kaufmann MW, Cassem N, Murray G, MacDonald D. The use of methylphenidate in depressed patients after cardiac surgery. J Clin Psychiatry 1984; 45: 82-84.
19. Fernandez F, Adams F, Holmes VF, Levy JK, Neidhart M. Methylphenidate for depressive disorders in cancer patients. Psychosomatics 1987; 28: 455-461.
20. Landman ME, Preisig R, Permlman M. A practical mood stimulant. J Med Soc NJ 1958; 55: 55-58.
21. Kaplitz SE. Withdrawn, apathetic geriatric patients responsive to methylphenidate. J Am Geriatr Soc 1975; 23: 271-276.
22. Mattes JA. Methylphenidate in mild depression: a double-blind controlled trial. J Clin Psychiatry 1985; 46: 525-527.
23. Janowsky DS, El-Yousef MK, Davis JM, Sekerke HJ. Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch Gen Psychiatry 1973; 28: 185-191.
24. Beckman VA, Heinemann H. d-Amphetamin beim manishen syndrom. Arzneimettelforschung 1976; 26: 1135-1136.
25. Brown WA, Mueller B. Alleviation of manic symptoms with catecholamine agonists. Am J Psychiatry 1979; 136: 230-231.
26. Garvey MJ, Hwang S, Teubner-Rhodes D, Zander J, Rhem C. Dextroamphetamine treatment of mania. J Clin Psychiatry 1978; 48: 412-413.
27. Kulesar IS. Amphetamine sulfate in mania. Lancet 1966; 1: 1164.
28. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
29. Bigelow LB, Berthot BD. The psychiatric symptom assessment scale (PSAS). Psychopharmcol Bull 1989; 25: 168-179.
30. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.